| OCUGEN INC. DL-,001 |
| USA |
| Gesundheit |
| US67577C1053 / A2PSZH |
| 2H51 (Frankfurt) / OCGN (NASDAQ) |
| FRA:2H51, ETR:2H51, 2H51:GR, NASDAQ:OCGN |
| - |
| https://ocugen.com/ |
|
Ocugen Inc. is a biopharmaceutical company focused..
>Volltext.. |
| 345.83 Mio. EUR |
| 346.17 Mio. EUR |
| 4.57 Mio. EUR |
| -48.02 Mio. EUR |
| -54.53 Mio. EUR |
| -0.18 EUR |
| 28.08 Mio. EUR |
| 27.74 Mio. EUR |
| -45.46 Mio. EUR |
| 1.6 |
| 8.41% |
| -18.77% |
| - |
| - |
| - |
| - |
| OCUGEN |
| 17.12.25 |
|
||||
|
||||
|